These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15654669

  • 1. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
    Berny W, Weiser A, Markowska-Woyciechowska A, Jarmundowicz W, Zub W, Załuski R.
    Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of expression of estrogen (ER) and progesterone receptors (PR) in brain glial tumors and its correlation with expression of p53 protein and proliferating cell nuclear antigen (PCNA)].
    Berny W, Weiser A, Jarmundowicz W, Markowska-Woyciechowska A, Załuski R, Zub W.
    Neurol Neurochir Pol; 2004; 38(5):367-71. PubMed ID: 15565522
    [Abstract] [Full Text] [Related]

  • 3. [Regarding the article by W. Berny i wsp. entitled "Expression of PCNA, Ki-67, AgNOR and p53 protein in brain glial tumors", published in the Polish Journal of Neurology and Neurosurgery no. 6/2004].
    Słowiński J.
    Neurol Neurochir Pol; 2005; 39(3):255-6; author reply 256. PubMed ID: 15981169
    [No Abstract] [Full Text] [Related]

  • 4. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
    Ben Rejeb A, Mahjoub A, Berraies N, Tissaoui K.
    Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
    [Abstract] [Full Text] [Related]

  • 5. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E.
    Br J Cancer; 1997 Aug; 75(9):1269-78. PubMed ID: 9155045
    [Abstract] [Full Text] [Related]

  • 6. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Aug; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
    Rammeh-Rommani S, Zermani R, Sfaxi M, Chabchoub A, Zouari B, Ayed M, Ben Jilani-Baltagi S.
    Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
    [Abstract] [Full Text] [Related]

  • 8. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A, Söylemez F, Ensari A.
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [Abstract] [Full Text] [Related]

  • 9. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV, Săftoiu A, Georgescu CC, Ciurea R, Ciurea T.
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
    Souza PE, Mesquita RA, Gomez RS.
    Oral Dis; 2000 Jan; 6(1):35-9. PubMed ID: 10673786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma.
    Malhan P, Husain N, Bhalla S, Gupta RK, Husain M.
    Indian J Pathol Microbiol; 2010 Jan; 53(1):20-3. PubMed ID: 20090216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H, Naudé S.
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [Abstract] [Full Text] [Related]

  • 20. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I.
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.